Drug Profile
Remdesivir controlled release - Starpharma
Alternative Names: DEP® remdesivirLatest Information Update: 14 Jan 2022
Price :
$50
*
At a glance
- Originator Starpharma
- Class Adenine nucleotides; Amines; Antivirals; Esters; Furans; Nitriles; Phosphorus compounds; Pyridazines; Pyrroles; Small molecules; Triazines
- Mechanism of Action RNA replicase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research COVID 2019 infections
Most Recent Events
- 03 Sep 2020 Starpharma has patent protection for composition and application of dendrimers in pharmaceutical, life-science and other fields (Starpharma website, September 2020)
- 03 Sep 2020 Starpharma has patents pending for composition and application of dendrimers in pharmaceutical, life-science and other fields (Starpharma website, September 2020)
- 03 Sep 2020 Early research in COVID-2019 infections in Australia (SC)